Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

7 results

  • Topics : Eye diseases
  • Active substance : latanoprost
Filter
Topic
  • Diseases and conditions (7)
  • Plus ...
    • Eye diseases (7)
  • Diagnostic and therapeutic techniques (6)
  • Plus ...
    • Drug therapy (6)
  • Population groups (3)
  • Plus ...
    • Paediatrics (3)
  • Economics and public health (1)
  • Plus ...
    • Health economics (1)
    • Screening, prevention (1)
Content type
  • Drugs, devices and medical acts (6)
  • Plus ...
    • Medicine (6)
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Public Health guideline (1)
Date
  • Last five years (2)
  • This year (2)
Language
  • Français (7)
Active substance
  • alcool (1)
  • brimonidine (1)
  • brinzolamide (1)
  • latanoprost (7)
  • pilocarpine (1)
 More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 1 result

  • Glaucoma: screening and early diagnosis – problems and outlook in France

    Public Health guideline - Posted on 1/7/2006 - Mis à jour le 29/3/2007
    Download abstract
    Add to my selection

Drugs, devices and medical acts - 6 results

  • CATIOLANZE (latanoprost)

    Medicine - Posted on 31/10/2024
    Add to my selection

  • LIFOG (latanoprost)

    Medicine - Posted on 3/10/2024
    Add to my selection

  • ROCLANDA (latanoprost/nétarsudil)

    Medicine - Posted on 4/8/2023
    Add to my selection
  • See 6 result in Drugs, devices and medical acts

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
9MVWVnkTys3huBW7